Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone

  title={Identification of the cytochrome P450 enzymes involved in the metabolism of domperidone},
  author={C. Simard and V. Michaud and B. Gibbs and R. Masse and E. Lessard and J. Turgeon},
  pages={1013 - 1023}
  • C. Simard, V. Michaud, +3 authors J. Turgeon
  • Published 2004
  • Biology, Medicine
  • Xenobiotica
  • 1. The objective was to identify the major cytochrome P450 enzyme(s) involved in the metabolism of domperidone. 2. Experiments were performed using human liver microsomes (HLMs), recombinant human cytochrome P450 enzymes, cytochrome P450 chemical inhibitors and monoclonal antibodies directed against cytochrome P450 enzymes. 3. Four metabolites were identified from incubations performed with HLMs and excellent correlations were observed between the formation of domperidone hydroxylated… CONTINUE READING
    21 Citations
    An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studies.
    • V. Michaud, C. Simard, J. Turgeon
    • Chemistry, Medicine
    • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
    • 2007
    • 28
    Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis
    • 7
    • Highly Influenced
    Identification of domperidone metabolites in plasma and urine of gastroparesis patients with LC–ESI-MS/MS
    • 5
    • Highly Influenced
    Domperidone interacts with pioglitazone but not with ondansetron via common CYP metabolism in vitro
    • 4
    Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes
    • 20
    Elucidation of in vitro phase I metabolites of droperidol using UPLC-QTOF MS
    Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions
    • 26


    Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    • 623
    Involvement of CYP2D6 activity in the N-oxidation of procainamide in man.
    • 20
    Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9.
    • 305
    Genetic polymorphism of cytochrome P450 3A5 in Chinese.
    • 85
    • PDF
    Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
    • 1,962
    • PDF
    Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist
    • J. Barone
    • Medicine
    • The Annals of pharmacotherapy
    • 1999
    • 209
    • Highly Influential
    Domperidone. A review of its use in diabetic gastropathy.
    • 38
    • Highly Influential
    Cardiac Arrhythmias during Cytotoxic Chemotherapy: Role of Domperidone
    • 39
    • Highly Influential